Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BeOne Medicines Ltd. - American Depositary Shares
(NQ:
ONC
)
316.99
-5.38 (-1.67%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BeOne Medicines Ltd. - American Depositary Shares
< Previous
1
2
3
4
Next >
BEONE MEDICINES LTD-ADR (NASDAQ:ONC) Passes Minervini's SEPA Screen with Strong Technicals and High Growth Momentum
↗
February 26, 2026
Via
Chartmill
BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership
February 26, 2026
From
BeOne Medicines Ltd.
Via
Business Wire
Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year
↗
February 23, 2026
Praxis Precision Medicines develops therapies for neurological and psychiatric disorders, aiming to address unmet needs in the CNS market.
Via
The Motley Fool
Topics
Regulatory Compliance
This Fund Bet Nearly $40 Million on GRAIL Last Quarter. The Stock Just Plunged Over 50%
↗
February 23, 2026
GRAIL develops advanced cancer detection technologies, serving healthcare providers and individuals seeking early diagnostic solutions.
Via
The Motley Fool
Topics
Regulatory Compliance
BEONE MEDICINES LTD-ADR (NASDAQ:ONC) Passes Minervini Trend Template and Strong Growth Scan
↗
January 21, 2026
Via
Chartmill
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
↗
February 21, 2026
Don't just buy these stocks. Hold onto them.
Via
The Motley Fool
Topics
Artificial Intelligence
Earnings
HHLR Advisors Fully Exits Baidu as AI Push Tests Its Advertising-Funded Model
↗
February 20, 2026
Baidu is transitioning from a search-driven advertising company into an AI infrastructure and enterprise cloud provider in China. HHLR’s exit comes as investors weigh whether this transformation will...
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
BeOne Medicines to Present at Upcoming Investor Conferences
February 17, 2026
From
BeOne Medicines Ltd.
Via
Business Wire
Prediction: These 3 Stocks Will Crush the Market in 2026
↗
February 16, 2026
These stocks all have catalysts on the way that could provide great news for investors.
Via
The Motley Fool
Topics
Artificial Intelligence
BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26
February 11, 2026
From
BeOne Medicines Ltd.
Via
Business Wire
3 Stocks to Buy in February
↗
February 02, 2026
These three stocks appear to be poised for strong performances in 2026.
Via
The Motley Fool
Topics
Artificial Intelligence
BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare Conference
January 13, 2026
From
BeOne Medicines Ltd.
Via
Business Wire
ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA
January 06, 2026
From
BeOne Medicines Ltd.
Via
Business Wire
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 23, 2025
From
BeOne Medicines Ltd.
Via
Business Wire
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma
December 18, 2025
From
BeOne Medicines Ltd.
Via
Business Wire
BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia
December 08, 2025
From
BeOne Medicines Ltd.
Via
Business Wire
BeOne Medicines Announced Sonrotoclax In Combination With BRUKINSA Demonstrated Rapid MRD Negativity In Treatment-naive CLL, Regardless Of High-risk Features
↗
December 07, 2025
BeOne Medicines Ltd. (NASDAQ:ONC, HKEX: 06160, SSE: 688235)), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating...
Via
Benzinga
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
December 07, 2025
From
BeOne Medicines Ltd.
Via
Business Wire
Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied
↗
November 26, 2025
Novo Nordisk stock jumped Wednesday on a lighter-than-feared discount for Ozempic and Wegovy under the IRA.
Via
Investor's Business Daily
Topics
Economy
Government
U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
November 26, 2025
From
BeOne Medicines Ltd.
Via
Business Wire
BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025
November 20, 2025
From
BeOne Medicines Ltd.
Via
Business Wire
Zymeworks, Jazz Pharmaceuticals Stocks Climb On Robust Gastroesophageal Trial Outcomes And Upcoming Regulatory Plans
↗
November 17, 2025
Zymeworks rises after Ziihera shows significant PFS and OS benefits in a Phase 3 trial, supporting plans for regulatory filings and guideline submissions.
Via
Benzinga
Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
November 17, 2025
From
BeOne Medicines Ltd.
Via
Business Wire
BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates
November 06, 2025
From
BeOne Medicines Ltd.
Via
Business Wire
BeOne Medicines to Present at Upcoming Investor Conferences
October 28, 2025
From
BeOne Medicines Ltd.
Via
Business Wire
Investor Exits $5.5 Million Perpetua Resources Stake Amid Stock's 150% Rally
↗
October 27, 2025
Investor Exits $5.5 Million Perpetua Resources Stake Amid Stock's 150% Rally
Via
The Motley Fool
Topics
Regulatory Compliance
BeOne Medicines to Announce Third Quarter 2025 Financial Results on November 6
October 22, 2025
From
BeOne Medicines Ltd.
Via
Business Wire
What's Going On With Summit Therapeutics Stock On Monday?
↗
October 20, 2025
Summit Therapeutics shares Phase 3 data showing ivonescimab cut cancer progression risk by 40% and plans BLA submission in late 2025.
Via
Benzinga
BeOne Medicines Presents New Data on TEVIMBRA in Lung Cancer at ESMO 2025
October 20, 2025
From
BeOne Medicines Ltd.
Via
Business Wire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
